LivaNova PLC (FRA:LIA)

Germany flag Germany · Delayed Price · Currency is EUR
54.00
0.00 (0.00%)
At close: Dec 4, 2025
9.31%
Market Cap 2.99B
Revenue (ttm) 1.15B
Net Income (ttm) -185.36M
Shares Out n/a
EPS (ttm) -3.40
PE Ratio n/a
Forward PE 15.87
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 27
Open 54.00
Previous Close 54.00
Day's Range 54.00 - 54.00
52-Week Range 29.60 - 55.00
Beta n/a
RSI 65.61
Earnings Date Feb 25, 2026

About LivaNova

LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products and therapies for neurological and cardiac conditions worldwide. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related accessories. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connect... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2015
Employees 2,900
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol LIA
Full Company Profile

Financial Performance

In 2024, LivaNova's revenue was $1.25 billion, an increase of 8.66% compared to the previous year's $1.15 billion. Earnings were $63.23 million, an increase of 260.39%.

Financial numbers in USD Financial Statements

News

There is no news available yet.